Application of muse cell therapy for kidney diseases

Nao Uchida, Naonori Kumagai, Yoshiaki Kondo

研究成果: Chapter

2 被引用数 (Scopus)


The kidney plays an essential role in the maintenance of homeostasis in healthy individuals, e.g., by regulating the amount of water and concentration of electrolyte in the body. Owing to the structural complexity, renal dysfunction is caused by a myriad of diseases and conditions, and in severe cases, it progresses to end-stage renal disease in which patients require renal replacement therapy, i.e., maintenance dialysis or kidney transplantation. The currently available therapeutic modalities, with the exception of renal transplantation, cannot recover severely deteriorated renal function. Thus, regenerative medicine holds considerable promise as a potential means for developing next-generation renal therapeutics. Mesenchymal stem cell (MSC) transplantation has been investigated in acute kidney injury and chronic kidney disease models, and clinical studies have already been started for some kinds of kidney diseases. However, most of these studies concluded that the main underlying mechanism of therapeutic effect of MSC transplantation was paracrine. Recently, we reported that Muse cell therapy in a murine model of chronic kidney disease resulted in differentiation of intravenously injected Muse cells into glomerular cells after preferential homing to damaged glomerulus and improvement in renal function. The result suggested the potentiality of Muse cell therapy for glomerular regeneration. Muse cells are a promising cell source for regenerative therapy for kidney diseases.

ホスト出版物のタイトルAdvances in Experimental Medicine and Biology
出版社Springer New York LLC
出版ステータスPublished - 2018


名前Advances in Experimental Medicine and Biology

All Science Journal Classification (ASJC) codes

  • 生化学、遺伝学、分子生物学(全般)


「Application of muse cell therapy for kidney diseases」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。